HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Increased binding and killing of neuraminidase-galactose oxidase-treated tumor cells by normal macrophages.

Abstract
The binding of Line 10 hepatoma cells to normal syngeneic guinea pig macrophages is increased when the tumor cells are treated with neuraminidase and galactose oxidase (NAGO) before they are added to the macrophage monolayers. The effect is abolished by exposure of the NAGO-treated tumor cells to sodium borohydride. Line 1 hepatoma cells treated with NAGO or with sodium periodate are killed to a greater extent than untreated tumor cells. This effect can also be reversed by sodium borohydride. Further, periodate-treated macrophages become cytotoxic for unmodified tumor cells. These results demonstrate that increased tumor cell killing occurs when artificial contacts (presumably via Schiff bases) are established between normal macrophages and tumor cells. They are consistent with the hypothesis that close cell to cell contact is necessary for macrophage-mediated cytotoxicity.
AuthorsW F Piessens
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 119 Issue 1 Pg. 167-72 (Jul 1977) ISSN: 0022-1767 [Print] United States
PMID194981 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Periodic Acid
  • Alcohol Oxidoreductases
  • Galactose Oxidase
  • Neuraminidase
Topics
  • Alcohol Oxidoreductases (pharmacology)
  • Animals
  • Binding Sites
  • Carcinoma, Hepatocellular (immunology)
  • Cell Adhesion
  • Cell Line
  • Cell Transformation, Neoplastic
  • Cytotoxicity Tests, Immunologic
  • Galactose Oxidase (pharmacology)
  • Guinea Pigs
  • Liver Neoplasms (immunology)
  • Macrophages (cytology, immunology)
  • Neoplasms, Experimental (immunology)
  • Neuraminidase (pharmacology)
  • Periodic Acid (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: